ABCG2 and cystic fibrosis: Potentiators of CFTR, like ivacaftor/VX-770 or SBC molecules, have been proven to rescue other ABC transporters such as ABCB4 and ABCB11 [76,77,78,79,80], expanding the potential therapeutic impact of these compounds beyond CF.